Will artificial intelligence find the cure for what ails us? AI pioneer and insitro CEO Daphne Koller is betting it will—at the very least—supercharge the hunt for new drugs. She breaks down her strategy in this Institute Dialogue with Paul McCracken, CPP Investments’ Managing Director Growth Equity and Nadeem Janmohamad, Managing Director Active Equities North America.

свернуть